A new model of pulmonary superinfection with Aspergillus fumigatus and Pseudomonas aeruginosa in mice.
We have produced a new model of pulmonary super-infection with Aspergillus fumigatus and Pseudomonas aeruginosa in immunosuppressed mice. Male ICR mice were given an intratracheal inoculation of 4 x 10(5) conidia of A. fumigatus in agar beads, and were immunosuppressed with 100 mg/kg subcutaneous injections of cortisone acetate on days 7, 9, 12, 14, and 16 after inoculation. Twelve days after inoculation, with the agar beads, the mice were challenged with the intranasal instillation of 2 x 10(6) CFU of P. aeruginosa. The survival rates of superinfected, A. fumigatus-alone, P. aeruginosa-alone, and non-infected mice were 50%, 30%, 90%, and 100% 14 days after pseudomonal infection (26 days after inoculation of A. fumigatus), respectively. In the superinfected mice, both A. fumigatus and P. aeruginosa were detected more than 10 days after pseudomonal infection (22 days after inoculation of A. fumigatus). Histopathological examination revealed peribronchial necrosis around A. fumigatus hyphae and inflammation by P. aeruginosa. This infection model in mice would be useful for studying the pathogenesis of superinfection.
Yonezawa
M
M
Research Laboratories, Toyama Chemical Co., Ltd., 2-4-1 Shimookui, Toyama 930-8508, Japan. MINORU_YONEZAWA@toyama-chemical.co.jp
Sugiyama
H
H
Kizawa
K
K
Hori
R
R
Mitsuyama
J
J
Araki
H
H
Shimakura
M
M
Minami
S
S
Watanabe
Y
Y
Yamaguchi
K
K
D000818:Animals; D001228:Aspergillosis / Q000473:pathology; D001232:Aspergillus fumigatus; D004195:Disease Models, Animal; D008171:Lung Diseases / Q000473:pathology; D008172:Lung Diseases, Fungal / Q000473:pathology; D051379:Mice; D011552:Pseudomonas Infections / Q000473:pathology; D015163:Superinfection / Q000473:pathology